Add time:07/20/2019 Source:sciencedirect.com
The evaluation of a new, orally active antihypertensive agent, S.9-390 (2-(o-chlorobenzyl) imidazoline hydrochloride), has been presented. In human beings, the drug was found to have effects suggesting both central antihypertensive and ganglionic blocking action, but no characteristic adrenolytic properties. Although toxicity was minimal, the development of drug resistance prohibits its wide clinical use in hypertensive disease. It presents, however, many desirable features of an antihypertensive agent, so that further clinical studies in this field are warranted.
We also recommend Trading Suppliers and Manufacturers of N-(2-CHLOROBENZYL)-1-BUTANAMINE HYDROCHLORIDE (cas 16183-40-7). Pls Click Website Link as below: cas 16183-40-7 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View